Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of citicoline on cognitive complications in bipolar manic patients receiving electroconvulsive therapy
IRCT20160523028008N9Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of citicoline in bipolar disorder (BD), sponsored by Hamadan University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
citicoline
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20160523028008N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160523028008N9.